Positive Phase 1 data supports Cyclacel’s plans for CDK2/9 inhibitor CYC065 Cyclacel faced a big failure in for its late-stage drug for leukemia just a year…
Phone
India: +91-11-45689769, +91-9650213330Address
New Delhi-110075, IndiaAddress
304 S. Jones Blvd #2432, Las Vegas NV 89107Phone
Outside India: +1(919)321-6187
